As the Ontario Dental Association‘s Annual Spring Meeting approaches, we at CDA Oasis are pleased to bring you highlights of some of the speakers and the sessions that will be offered this year. It is my hope that you learn from the various conversations; and if you happen to be in Toronto, you find it interesting enough to attend the event.
Dr. Deborah Saunders is the Medical Director of the Department of Dental Oncology and Assistant Professor at the Northern Ontario School of Medicine in Sudbury, Ont. She is a global adviser on the subject of osteonecrosis of the jaw and holds positions for guideline development on the management of this side-effect with the International Society of Oral Oncology and the American Society of Clinical Oncology. Her clinical and research interests include multilingual knowledge transfer for oral care in the oncology patient, systematic review and guideline development for the nine oral complications in cancer therapy and clinical research in clinical tobacco intervention, osteonecrosis of the jaw and oral mucositis.
ASM2018 is the single largest venue where the dental team members can earn continuing education credits all under one roof. The meeting offers a broad and diverse range of renowned speakers and topics for dentists, dental hygienists, dental assistants and office staff. There will be lectures, workshops and various exhibitors, showcasing the latest products and services from more than 300 companies.
I hope you benefit from the information presented in this conversation. Be sure to share your thoughts, suggestions, and questions with us at email@example.com
Until next Time!
Chiraz Guessaier, CDA Oasis Manager
It is estimated that by 2020, the confi rmed cases of head and neck cancers caused by the human papillomavirus (HPV) will surpass the rates of cervical cancer in North America. These patients are not your typical cancer patients and for those reasons can remain undiagnosed until they present with later stage disease. This can be avoided by following the fundamentals of a thorough head and neck examination, which is most often key to early detection in this patient population.
The session will allow attendees to:
- You will become familiar with the HPV and how it is involved in cancer development
- Risk factors will be discussed
- Myths and facts about HPV oropharyngeal cancers will be reviewed, with a special emphasis on how to talk to your patients about what, for most, is an uncomfortable topic to discuss
The session will take place April 27 at 2:00 – 4:30 pm.
Full Interview (6.51″)